brentuximab vedotin
seagen
['lymphoma', 'echelon2', 't-cell lymphoma', 'cml']
zinzani: periph t-cell lymphoma.
-treat acc to histology? some subtypes spec treatm. echelon2 (bv-chp) for cd30+ (spec alcl) still only pos phase iii.
-asct primary necessary? seems to add to results.
-new drugs in r/r.
unmet needs.
#17icml 
Oncologist at Uppsala university hospital. Chair of the Swedish lymphoma group (SLG) and the Swedish Hodgkin lymphoma group.